欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	SE/H/1849/001
药品名称	Fenylefrin Aguettant
活性成分	PHENYLEPHRINE HYDROCHLORIDE 100.0 µg/ml
剂型	Solution for injection/infusion
上市许可持有人	Laboratoire Aguettant
参考成员国 - 产品名称	Sweden (SE) Fenylefrin Aguettant
互认成员国 - 产品名称	Germany (DE) Denmark (DK) Phenylephrin "Aguettant" Belgium (BE) Netherlands (NL) Luxembourg (LU) United Kingdom (Northern Ireland) (XI) Ireland (IE) Austria (AT) Phenylephrin Aguettant 100 Mikrogramm/ml Injektions-/Infusionslösung France (FR) Spain (ES) Portugal (PT) Italy (IT) Norway (NO) Fenylefrin Aguettant Finland (FI) Poland (PL) Phenylephrine Aguettant Romania (RO)
许可日期	2019/12/19
最近更新日期	2024/01/16
药物ATC编码	C01CA06 phenylephrine
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Initial Application TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	PAR Summary \| Fenylefrin%20Aguettant%20100%20mikrogram%20per%20ml,%20Solution%20for%20injection%20or%20infusion%20ENG%20sPAR_09001bee8139d5ae.pdfDate of last change:2022/05/14 PAR \| Fenylefrin%20Aguettant%20100%20mikrogram%20per%20ml,%20Solution%20for%20injection%20or%20infusion%20ENG%20PAR_09001bee8139d5ad.pdfDate of last change:2022/05/14 Final PL \| SE/H/1849/001_Final PLDate of last change:2020/02/20 Final SPC \| SE/H/1849/001_Final SPCDate of last change:2020/02/20
市场状态	Positive